We value your privacy

We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.

kindr currently serves patients in the United States only. Content is for informational purposes elsewhere.
Peptides shop · Fusion Inhibitory Peptide · Reference sheet

Fusion Inhibitory Peptide

Reference sheet · Coagulation · CPC catalog code FIP-001

Identity

Name
Fusion Inhibitory Peptide
Catalog code
FIP-001
Category
Coagulation

Physicochemical properties

Sequence
Z-DPhe-Phe-Gly-OH

Handling, storage & reconstitution

Upstream storage
CONDITIONS:**-20 ± 5 °C

General guidance for this class

Reference standards in the Coagulation class are typically shipped as lyophilized powder and stored desiccated at −20 °C protected from light. Once reconstituted in bacteriostatic water or the assay-appropriate buffer, aliquot and store at −80 °C to minimize freeze–thaw cycles. Confirm handling requirements against your institutional biosafety and radiation protocols before use.

Mechanism & research applications

Fusion Inhibitory Peptide sits within the Coagulation research class (CPC reference FIP-001). Coagulation peptides act either as chromogenic / fluorogenic substrates for thrombin, FXa, FVIIa, plasmin, and related proteases, or as inhibitors and receptor ligands (e.g. PAR-1/4 activators) that dissect specific cascade nodes. Investigators typically incorporate Fusion Inhibitory Peptide as a reference standard, tool ligand, or substrate in the assay contexts listed above. Read on kinetic plate readers at 405 nm (pNA) or fluorescence (AMC / MCA) endpoints.

Studied for

  • Chromogenic protease-activity assays
  • PAR (protease-activated receptor) signaling studies
  • Antithrombotic and anticoagulant screening
  • Fibrinolysis and clot-lysis kinetics

Frequently asked

What is Fusion Inhibitory Peptide?

Fusion Inhibitory Peptide (CPC catalog code FIP-001) is a synthetic coagulation cascade peptide / substrate in the coagulation category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.

What is Fusion Inhibitory Peptide studied for?

Published and internal research programs use Fusion Inhibitory Peptide as a reference standard in coagulation workflows — for example, chromogenic protease-activity assays and par (protease-activated receptor) signaling studies. Human clinical evidence is not established.

Is Fusion Inhibitory Peptide FDA-approved for human use?

No. Fusion Inhibitory Peptide is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.

How is Fusion Inhibitory Peptide typically used in the lab?

In a coagulation workflow, Fusion Inhibitory Peptide is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. Read on kinetic plate readers at 405 nm (pNA) or fluorescence (AMC / MCA) endpoints.

Sources

View full product page →Back to catalog

Related peptides in Coagulation

Other reference standards in the same class — commonly cross-referenced during assay design and comparator selection.

Fibrinogen-Binding Peptide
Tryptophan Motif Peptide
Hemoglobin (Hb) (64-76)
Scrambled TRAP Fragment
FITC-beta-Ala-NYAD-1 (NYAD-2)
Thrombin Receptor Peptide Ligand
Thrombin substrate
Thrombin Sensitive Peptide (Acid)
Research use only. The peptides referenced on this page are supplied to qualified laboratories for in-vitro or non-human research. They are not drugs, foods, cosmetics, or dietary supplements, are not for human consumption, and are not intended to diagnose, treat, cure, or prevent any disease. Physicochemical values shown here are transcribed from the cited upstream reference sheet(s); confirm with your own certificate of analysis before use.
Ask Dot